Netherlands· NL-e6eee7bc8408

Olmesartan medoxomil / Amlodipine / HCTZ Win Medica 40/10/12,5 mg, filmomhulde tabletten

A olmesartan medoxomil, amlodipin und hydrochlorothiazid product containing amlodipinebesilaat + hydrochloorthiazide + olmesartanmedoxomil, registered in Netherlands by Win Medica S.A.. The same ATC class is registered in 9 of our 19 countries.

ATC C09DX03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about amlodipinebesilaat + hydrochloorthiazide + olmesartanmedoxomilAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Olmesartan medoxomil, amlodipin und hydrochlorothiazid is registered in 9 of 19 countries.

Countries holding a registration under ATC C09DX03 (olmesartan medoxomil, amlodipin und hydrochlorothiazid), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search olmesartan medoxomil, amlodipin und hydrochlorothiazid products by name

Olmesartan medoxomil, amlodipin und hydrochlorothiazid · ATC C09DX03

9 / 19 countries

Belgiumprice
Czechiaprice
Finlandprice
Ireland
Italyprice
Netherlands
Polandprice
Spainprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: AMLODIPINEBESILAAT + HYDROCHLOORTHIAZIDE + OLMESARTANMEDOXOMIL
Manufacturer: Win Medica S.A.
Country: Netherlands (NL)
ATC code: C09DX03
ATC class: Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
126867

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

36 interactions on record for olmesartan medoxomil, amlodipin und hydrochlorothiazid.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check olmesartan medoxomil, amlodipin und hydrochlorothiazid against other medicines How interaction checks work

Olmesartan medoxomil, amlodipin und hydrochlorothiazid · interactions on record

36 records

36 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same class

Other records under C09DX03

Olmesartan medoxomil, amlodipin und hydrochlorothiazid, as other registers publish it.

All olmesartan medoxomil, amlodipin und hydrochlorothiazid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f46cda1e-2eaf-4e4f-8500-c5a9d5454b24
GET /v1/drugs/f46cda1e-2eaf-4e4f-8500-c5a9d5454b24?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h126867_smpc_en.pdf",
  "strength": null,
  "atc_label": "Olmesartan medoxomil, amlodipine and hydrochlorothiazide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126867",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "AMLODIPINEBESILAAT",
    "HYDROCHLOORTHIAZIDE",
    "OLMESARTANMEDOXOMIL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126867_piluk.pdf",
  "authorised_at": "2021/08/30",
  "procedure_number": "NL/H/5221/004",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "126867",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about olmesartan medoxomil, amlodipin und hydrochlorothiazid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console